Sigachi Industries Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Micro Crystalline Cellulose Powder(MCCP): 83.8% • Operational and Maintenance Income: 8.5% • Others: 7.6%
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has delivered good profit growth of 28.2% CAGR over last 5 years
- Latest quarter profit grew 108.1% YoY, showing strong momentum
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 28.6% CAGR over last 5 years
- Company comfortably covers its interest (8.4x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Promoter holding has decreased over last 2 years: -8.7pp
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.40x)
- Free cash flow has been persistently negative
- Equity base is being diluted - shares outstanding up 24.3%
- Working capital days have increased from 115 to 156 days
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | 1899.00 | 37.67 | 455633.71 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| DIVISLAB | 9100.00 | 82.59 | 241576.41 | 0.33 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| TORNTPHARM | 4850.00 | 84.58 | 184478.41 | 0.78 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| CIPLA | 1385.00 | 33.19 | 111888.39 | 0.94 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| ZYDUSLIFE | 1121.00 | 24.78 | 111820.18 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| LAURUSLABS | 1840.00 | 90.93 | 99417.45 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| LUPIN | 2111.00 | 17.46 | 96528.82 | 0.85 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| DRREDDY | 1154.00 | 29.89 | 96322.06 | 0.69 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| MANKIND | 2328.55 | 47.09 | 96179.61 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| AUROPHARMA | 1653.30 | 25.62 | 95127.23 | 0.24 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| GLENMARK | 2427.00 | 38.10 | 68495.93 | 0.10 | 482.83 | 927.88 | 4018.48 | 31.35 | 20.35 | 20.03 |
| SIGACHI | 34.62 | 52.18 | 1322.89 | 0.00 | 81.45 | 180.67 | 1212.74 | 845.64 | 16.42 | 13.62 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85 | 99 | 111 | 104 | 96 | 125 | 139 | 128 | 128 | 110 | 117 | 122 | 121 | |
| 68 | 78 | 88 | 88 | 75 | 108 | 106 | 100 | 104 | 103 | 112 | 105 | 112 | |
| Operating Profit | 16 | 21 | 23 | 16 | 21 | 17 | 33 | 29 | 24 | 8 | 6 | 16 | 9 |
| OPM % | 19.26% | 21.60% | 20.36% | 15.68% | 21.96% | 13.79% | 23.80% | 22.28% | 18.80% | 6.81% | 4.87% | 13.46% | 7.49% |
| 2 | 1 | 2 | 7 | 2 | 15 | 2 | 2 | -117 | 7 | -0 | 0 | 1 | |
| Interest | 1 | 2 | 2 | 3 | 3 | 2 | 4 | 3 | 3 | 3 | 3 | 4 | 3 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 5 | 5 | 5 | 4 | 4 | 5 | 4 |
| Profit before Tax | 15 | 18 | 20 | 17 | 16 | 27 | 27 | 23 | -101 | 7 | -2 | 8 | 10 |
| Tax % | 26.04% | 17.01% | 18.02% | 11.85% | 22.15% | 20.83% | 23.17% | 28.67% | 0.02% | -41.67% | 99.46% | 0.91% | 19.28% |
| Net Profit | 0 | 0 | 0 | 0 | 13 | 21 | 21 | 16 | -101 | 11 | -0 | 8 | 8 |
| 0.35 | 0.49 | 0.51 | 0.48 | 0.40 | 0.66 | 0.65 | 0.39 | -2.63 | 0.28 | 0.01 | 0.20 | 0.18 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 101 | 129 | 139 | 193 | 250 | 302 | 399 | 488 | 471 | |
| 89 | 103 | 114 | 154 | 197 | 243 | 322 | 388 | 432 | |
| Operating Profit | 12 | 26 | 25 | 39 | 53 | 59 | 77 | 100 | 39 |
| OPM % | 11.65% | 20.13% | 17.80% | 20.12% | 21.19% | 19.44% | 19.21% | 20.48% | 8.22% |
| 3 | 4 | 5 | 3 | 3 | 7 | 12 | 21 | 8 | |
| Interest | 4 | 3 | 2 | 1 | 1 | 4 | 8 | 12 | 14 |
| Depreciation | 1 | 2 | 2 | 2 | 3 | 7 | 11 | 16 | 17 |
| Profit before Tax | 10 | 25 | 25 | 38 | 52 | 54 | 70 | 92 | 23 |
| Tax % | 27.91% | 23.11% | 19.84% | 21.37% | 22.41% | 20.09% | 17.92% | 23.68% | -12.51% |
| Net Profit | 7 | 19 | 20 | 30 | 40 | 44 | 57 | 70 | 26 |
| EPS | 22.53 | 61.87 | 26.44 | 13.13 | 15.44 | 14.16 | 1.74 | 1.82 | — |
| Dividend Payout % | 4.44% | 1.62% | 3.78% | 2.54% | 7.68% | 7.06% | 5.74% | 5.49% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 29%
- 3 Years:
- 25%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 28%
- 3 Years:
- 20%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -1%
- 1 Year:
- 11%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 23%
- 3 Years:
- 17%
- Last Year:
- 14%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 8 | 8 | 31 | 31 | 33 | 38 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 12 |
| 23 | 42 | 57 | 87 | 197 | 238 | 339 | 563 | |
| 30 | 25 | 30 | 21 | 35 | 64 | 139 | 140 | |
| Trade Payables | 8 | 9 | 7 | 8 | 11 | 21 | 48 | 36 |
| 7 | 13 | 7 | 10 | 14 | 20 | 124 | 58 | |
| Total Liabilities | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 |
| 26 | 29 | 32 | 38 | 53 | 122 | 254 | 370 | |
| Capital Work in Progress | 1 | 2 | 3 | 4 | 10 | 35 | 97 | 9 |
| 16 | 23 | 28 | 21 | 30 | 47 | 71 | 94 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 150 | 184 | |
| Cash & Bank | 3 | 2 | 11 | 18 | 69 | 33 | 57 | 72 |
| 27 | 36 | 36 | 52 | 124 | 137 | 65 | 117 | |
| Total Assets | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 9 | 19 | 17 | 36 | 17 | 42 | 13 | 27 | |
| Cash from Investing | -4 | -6 | -7 | -11 | -63 | -92 | -161 | -93 |
| Cash from Financing | -3 | -9 | 3 | -11 | 108 | 26 | 172 | 81 |
| -1 | -0 | 8 | 7 | 51 | -37 | 24 | 15 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| PER SHARE | ||||||||
| EPS (₹) | 22.53 | 61.87 | 26.44 | 39.39 | 13.02 | 14.16 | 1.74 | 1.82 |
| Book Value (₹) | 85.72 | 146.06 | 84.07 | 122.62 | 74.09 | 87.29 | 11.32 | 15.72 |
| Dividend per Share (₹) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.10 | 0.10 |
| Cash EPS (₹) | 0.36 | 0.90 | 0.97 | 1.41 | 1.40 | 1.63 | 2.07 | 2.26 |
| PROFITABILITY | ||||||||
| Operating Margin % | 14.68% | 23.14% | 21.32% | 21.81% | 22.24% | 21.65% | 19.21% | 20.48% |
| Net Margin % | 6.87% | 14.74% | 14.61% | 15.70% | 16.00% | 14.41% | 14.35% | 14.43% |
| ROE % | 26.28% | 53.39% | 37.12% | 38.11% | 24.87% | 17.55% | 17.90% | 14.49% |
| ROCE % | 23.60% | 44.44% | 33.55% | 37.83% | 27.93% | 20.53% | 17.90% | 16.42% |
| 9.58% | 23.22% | 20.25% | 24.95% | 19.06% | 13.18% | 10.73% | 9.15% | |
| EFFICIENCY | ||||||||
| Debtor Days | 77 | 65 | 69 | 60 | 70 | 85 | 105 | 125 |
| Inventory Days | 58 | 55 | 66 | 47 | 38 | 47 | 54 | 62 |
| Payable Days | 52 | 47 | 41 | 28 | 29 | 41 | 64 | 69 |
| 83 | 72 | 94 | 79 | 79 | 90 | 95 | 118 | |
| FINANCIAL HEALTH | ||||||||
| Debt to Equity (x) | 1.15x | 0.56x | 0.47x | 0.22x | 0.15x | 0.15x | 0.34x | 0.20x |
| Interest Coverage (x) | 3.53x | 8.17x | 11.81x | 31.79x | 45.08x | 13.69x | 9.98x | 8.44x |
| 1.11x | 1.41x | 1.84x | 2.71x | 3.50x | 2.38x | 1.67x | 2.13x | |
| GROWTH | ||||||||
| Revenue Growth % | 0.00% | 28.05% | 7.81% | 38.61% | 29.85% | 20.68% | 32.08% | 22.38% |
| Operating Profit Growth % | 0.00% | 101.89% | -0.69% | 41.82% | 32.42% | 17.46% | 35.08% | 36.41% |
| Net Profit Growth % | 0.00% | 174.65% | 6.85% | 48.95% | 32.31% | 8.74% | 31.54% | 23.04% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -87.70% | 4.49% | |
| VALUATION | ||||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 32.04x | 19.30x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 4.93x | 2.23x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.28% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 21.53x | 11.52x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-08-25 - Sigachi Industries Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-24 - Sigachi Industries Limited has informed the Exchange regarding Notice of undefined to be held on September 15, 2026
2026-08-24 - Sigachi Industries Limited has informed the Exchange about General Updates for Correction in Annexure A of the Outcome of Board Meeting held on August 22, 2026
2026-08-22 - Sigachi Industries Limited has informed the Exchange about change in Management- Resignation and Appointment of Internal Auditors
2026-08-22 - Sigachi Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2026.
2026-08-20 - Sigachi Industries Limited has informed the Exchange about Transcript
2026-08-14 - Sigachi Industries Limited has informed the Exchange about Copy of Newspaper Publication
2026-08-13 - Monitoring Agency Report for the quarter ended June 30, 2026
2026-08-13 - Sigachi Industries Limited has informed the Exchange about Link of Recording
News
Recent coverage and analyst commentary for SIGACHI
Loading news…
AI Stock Analyst
Sigachi Industries Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account